{
    "clinical_study": {
        "@rank": "110878", 
        "arm_group": [
            {
                "arm_group_label": "Additional instillation of hyaluronic acid/chondroitin sulfate", 
                "arm_group_type": "Experimental", 
                "description": "Transurethral resection of bladder ulcer + instillation of hyaluronic acid/chondroitin sulfate"
            }, 
            {
                "arm_group_label": "Transurethral resection of bladder ulcer", 
                "arm_group_type": "Active Comparator", 
                "description": "Transurethral resection of bladder ulcer"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate efficacy and safety of additional hyaluronic\n      acid/chondroitin sulfate  to transurethral resection of bladder ulcer in patient with\n      interstitial cystitis."
        }, 
        "brief_title": "The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Interstitial Cystitis", 
        "condition_browse": {
            "mesh_term": [
                "Cystitis", 
                "Cystitis, Interstitial"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a randomized, parallel, 6 month period study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. must have experienced bladder pain, urinary urgency and urinary frequency, for at\n             least 6 months prior to entry into the study\n\n          2. Pain VAS \u22654\n\n          3. O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) symptom and problem \u2265 12( and\n             pain \u22652, and nocturia \u2265 2)\n\n          4. PUF score \u2265 13\n\n          5. cystoscopic record within 2 years\n\n          6. Hunner ulcer lesion in cystoscopic finding\n\n        Exclusion Criteria:\n\n          1. Scheduled for or use of intravesical therapy (eg, bladder distention,transurethral\n             resection of bladder ulcer, instillation) during or within 6months prior to the study\n             and use of pentosan polysulfate sodium within 1 months prior to the study\n\n          2. Patients  who are pregnancy or, childbearing age without no contraception\n\n          3. Patients with voided volume <40 or, > 400ml\n\n          4. Patients with microscopic hematuria, (\u22651+ in dipstick), If not excluded that no\n             evidence of neoplastic tumor examination\n\n          5. Patients with urine culture showing evidence of urinary tract infection 1month prior\n             to the study\n\n          6. Accompanied medical problem below\n\n               -  Tuberculosis in urinary system\n\n               -  Bladder cancer, urethral cancer, prostate cancer\n\n               -  Recurrent cystitis\n\n               -  anatomical disorder\n\n          7. Patients had prior surgery (eq, bladder augmentation, cystectomy\n\n          8. Patients with neurologic disorder\n\n          9. Patients with indwelling catheter or intermittent self-catheterization\n\n         10. Patients with psychologic problem"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01813565", 
            "org_study_id": "20130135"
        }, 
        "intervention": {
            "arm_group_label": [
                "Additional instillation of hyaluronic acid/chondroitin sulfate", 
                "Transurethral resection of bladder ulcer"
            ], 
            "description": "Additional Hyaluronic acid/chondroitin sulfate instillation to the bladder", 
            "intervention_name": "Hyaluronic acid/chondroitin sulfate", 
            "intervention_type": "Drug", 
            "other_name": "Ialuril"
        }, 
        "intervention_browse": {
            "mesh_term": "Hyaluronic Acid"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "contact": {
                "email": "mschoo@amc.seoul.kr", 
                "last_name": "Myung-Soo Choo, professor", 
                "phone": "82-2-3010-3735"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Asan medical center"
            }, 
            "investigator": {
                "last_name": "Myung-Soo Choo", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.", 
        "overall_contact": {
            "email": "mschoo@amc.seoul.kr", 
            "last_name": "Myung-Soo Choo, professor", 
            "phone": "82-2-3010-3735"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Myung -Soo Choo, profesor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change of pain scores on the Visual Analogue Scale", 
            "safety_issue": "Yes", 
            "time_frame": "1month, 3month, 6month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01813565"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Myung-Soo Choo", 
            "investigator_title": "Profesor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Duration of symptom improvement", 
                "safety_issue": "No", 
                "time_frame": "1month, 3month, 6month"
            }, 
            {
                "measure": "Changes of frequency and urgency on voiding diary", 
                "safety_issue": "No", 
                "time_frame": "1month, 3month, 6month"
            }, 
            {
                "measure": "Change score of O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q)", 
                "safety_issue": "No", 
                "time_frame": "1month, 6month"
            }, 
            {
                "measure": "Score of Global Response Assessment (GRA), Patient Global Assessment (PGA) score", 
                "safety_issue": "No", 
                "time_frame": "6month"
            }, 
            {
                "measure": "Occurrence of adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "6month"
            }, 
            {
                "measure": "Change score of Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF)", 
                "safety_issue": "No", 
                "time_frame": "1month, 6month"
            }, 
            {
                "measure": "Change score of EQ-5D Health Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "1month, 6month"
            }, 
            {
                "measure": "Change score of Brief Pain Inventory-short form (BPI-sf)", 
                "safety_issue": "No", 
                "time_frame": "1month, 6month"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}